Blueprint Medicines (BPMC) Analysts See $-0.73 EPS, National Beverage (FIZZ)’s Sentiment Is 1.14

Analysts expect Blueprint Medicines Corp (NASDAQ:BPMC) to report $-0.73 EPS on May, 9.They anticipate $0.16 EPS change or 28.07% from last quarter’s $-0.57 EPS. After having $-0.75 EPS previously, Blueprint Medicines Corp’s analysts see -2.67% EPS growth. The stock decreased 6.87% or $3.23 during the last trading session, reaching $43.81. About shares traded. Blueprint Medicines Corp (NASDAQ:BPMC) has risen 58.04% since September 27, 2016 and is uptrending. It has outperformed by 47.48% the S&P500.

National Beverage Corp. is a holding company. The company has market cap of $4.33 billion. The Firm develops, produces, markets and sells a diverse portfolio of flavored beverage products primarily in North America. It has a 44.65 P/E ratio. The Company’s brands consist of beverages geared to the active and health-conscious consumer , including sparkling waters, energy drinks and juices, and carbonated soft drinks in a range of flavors, including regular, sugar-free and reduced calorie options.

Among 4 analysts covering Blueprint Medicine Corp (NASDAQ:BPMC), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Blueprint Medicine Corp had 5 analyst reports since February 22, 2016 according to SRatingsIntel. The stock has “Buy” rating by Canaccord Genuity on Friday, August 5. Goldman Sachs upgraded Blueprint Medicines Corp (NASDAQ:BPMC) on Monday, March 13 to “Buy” rating. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. The stock of Blueprint Medicines Corp (NASDAQ:BPMC) earned “Outperform” rating by Raymond James on Friday, May 27.

Blueprint Medicines Corporation is a biopharmaceutical company. The company has market cap of $1.66 billion. The Firm focuses on patients with genomically defined diseases driven by abnormal kinase activation. It currently has negative earnings. It focuses on crafting drug candidates that provide clinical responses to patients without adequate treatment options.

Analysts await National Beverage Corp. (NASDAQ:FIZZ) to report earnings on July, 13.

Clovis Capital Management Lp holds 13.07% of its portfolio in National Beverage Corp. for 25,040 shares. Newtyn Management Llc owns 650,000 shares or 5.5% of their US portfolio. Moreover, Sandler Capital Management has 0.64% invested in the company for 140,320 shares. The New York-based Hap Trading Llc has invested 0.61% in the stock. Zebra Capital Management Llc, a Connecticut-based fund reported 38,066 shares.